[Cardiovascular-active agents. Problems of dosage and adverse effects].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001919:Bradycardia / Q000628:therapy; D002301:Cardiac Glycosides / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D010138:Pacemaker, Artificial; D013565:Sympatholytics / Q000008:administration & dosage*; D013610:Tachycardia / Q000628:therapy; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D013565:Sympatholytics; D014665:Vasodilator Agents
Herz- und Kreislaufmittel. Probleme der Dosierung und Nebenwirkungen.